Basecamp Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Basecamp Wealth Advisors's ABBV Position: Q3 2026 in Review
Basecamp Wealth Advisors reduced its AbbVie (ABBV) stake by 39% in Q3 2026, selling an estimated $775K and leaving 4,700 shares worth $1.23M. The position accounts for 0.28% of the portfolio, ranked #31.
Basecamp Wealth Advisors first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.94M in Q2 2026. 4,228 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Basecamp Wealth Advisors held 4,700 shares of AbbVie worth $1.23M as of Q3 2026.
- Basecamp Wealth Advisors sold 3,022 AbbVie shares in Q3 2026, an estimated $775K.
- AbbVie made up 0.28% of Basecamp Wealth Advisors's portfolio in Q3 2026, its #31 holding.
- Basecamp Wealth Advisors first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- Basecamp Wealth Advisors's AbbVie position peaked at $1.94M in Q2 2026.
- 4,228 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Basecamp Wealth Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.